Kiran Mazumdar Shaw

Managing Director

Ms. Shaw is a first-generation entrepreneur with over 44 years of experience in the field of biotechnology. She is a recipient of ‘Padma Shri’ and the ‘Padma Bhushan’ awards. She was also conferred with the highest French distinction – Chevalier de l’Ordre National de la Légion ’Honneur (Knight of the Legion of Honour) in 2016. She is ranked #1 in the Business Captains category in Global ‘Medicine Maker Power List’ 2018. Ms. Shaw is the only Indian in the Hurun Global Self-Made Women Billionaires List 2017. She is also the Chairperson and Managing Director of Biocon Limited, Independent Director on the Board of Infosys and United Breweries Ltd.


Jonathan Hunt

Whole-time Director and Chief Executive Officer

Mr. Hunt is an MBA from Durham University, United Kingdom, with over 25 years of experience in the global biopharmaceuticals industry. At Syngene, he is responsible for leading the Company’s business operations and steering its investments in developing and strengthening its capabilities and capacities. He held various leadership positions at Astrazeneca for over a decade, including President and Director of Astrazeneca, Austria, and President and Chief Operating Officer (COO), Astrazeneca, India.


John Shaw

Non-Executive Director

Mr. Shaw has a postgraduate degree in Arts (Economic Hons.) in History and Political Economy from Glasgow University, United Kingdom. Currently, he is the Non-Executive Vice-Chairman of Biocon Limited. Before joining Biocon, he worked with Coats Viyella Plc. for 27 years and served as Finance Director and Managing Director of the Coats Viyella group companies. He is also the former Chairman of Madura Coats Limited.


Dr. Bala S. Manian

Independent Director

Mr. Manian has over 35 years’ experience in the realms of biomedical sciences. Along with a postgraduate degree in Optics from the University of Rochester, United States, he also earned his doctorate in Mechanical Engineering from Purdue University, United States. He has more than 40 patents registered in the field of physics, engineering and biomedical sciences. He was felicitated with Technical Academy Award by the Academy of Motion Picture Arts and Sciences in February 1999 for advances in digital cinematography. Dr. Bala S.Manian is a Chairman of Nomination and Remuneration Committee and CorporateSocial Responsibility Committee, and a member of Risk Management Committee.


Suresh Talwar

Independent Director

Mr S.N. Talwar is a graduate in commerce and law of the Bombay University. He is also an Advocate and Solicitor of the Bombay High Court. When in active practice, he specialised in corporate laws including corporate tax. He is on the Board of Proctor and Gamble Health Limited, Sonata Software Limited and Elantas Beck Limited. He is also on a few private companies such as Johnson & Johnson, Aditya Birla Trustee Company, among others. He was a senior partner at Crawford Bayley and Co. till 2006. He subsequently launched and retired from his own law firm ‘Talwar Thakore and Associates’, which he ran in association with Shobhan Thakore. Suresh Talwar is a member of Audit Committee, Nomination and Remuneration Committee, Corporate Social Responsibility Committee and Risk Management Committee, and a Chairman of Stakeholders Relationship Committee.


Professor Catherine Rosenberg

Non-Executive Director

Professor Rosenberg received her Diplome d’Ingénieur’ from the Ecole Nationale Superieure des Telecommunications de Bretagne and an M.S. (Computer Science) from the University of California. She also earned a ‘Doctorat en Sciences’ from the Universite de Paris XI. She is a Fellow Member of the Institute of Electrical and Electronics Engineers and was elected a Fellow Member of the Canadian Academy of Engineering in 2013. At present, Prof. Rosenberg is the Canada Research Chair in the Future Internet, the Cisco Research Chair in 5G Systems and a professor in electrical and computer engineering at the University of Waterloo, Canada. Professor Catherine Rosenburg is a member of Nomination and Remuneration Committee, Corporate Social Responsibility Committee and Risk Management Committee.


Russell Walls

Independent Director

Mr. Walls is a Fellow Member of the Association of Chartered Certified Accountants, United Kingdom. With an experience of over 45 years in the field of finance, his expertise ranges across industries such as pharmaceuticals, insurance, textiles, transport and leisure. Currently, he is on the board of Biocon Limited where he chairs the Audit Committee and Risk Management Committee and he is a Chairman of Aviva Italia Holdings SpA and a Director on the Board of Neuseren SA. Russell Walls is a member of Audit Committee, Stakeholders Relationship Committee and Risk Management Committee.


Paul Blackburn

Independent Director

Mr. Blackburn is a graduate in Management Sciences from Warwick University, United Kingdom, and has a professional accounting qualification from Institute of Cost and Management Accountants, United Kingdom. With more than 40 years experience in the field of finance, he worked as senior finance executive at GlaxoSmithKline, UK. Currently, he is also on the Board of Mereo Biopharma Group Plc. Paul Blackburn is a Chairman of Audit Committee and Risk Management Committee, and a member of Stakeholders Relationship Committee.


Dr. Vijay Kuchroo

Independent Director

Dr. Kuchroo has a doctorate in Pathology from the University of Queensland, Australia. He is also the Samuel L. Wasserstrom Professor of Neurology at the Harvard Medical School, United States, and has 25 patents and over 325 research papers in immunology. He is a Member of the Scientific Advisory Boards of leading pharmaceutical companies including Pfizer, Novartis and GSK. He founded five different biotech companies including CoStim Pharmaceuticals and Tempero Pharmaceuticals. Dr. Vijay Kuchroo is a member of Nomination and Remuneration Committee, Corporate Social Responsibility Committee and Risk Management Committee.


Vinita Bali

Independent Director

Ms. Bali is a global business leader with extensive experience in leading large companies both in India and overseas. She served as Chief Executive Officer/ MD of Britannia Industries from 2005 to 2014. Prior to that, she worked with eminent multinationals like The Coca-Cola Company and Cadbury Schweppes Plc in a variety of marketing, general management and chief executive roles across the globe. Ms. Bali serves as an advisory board member of PwC India and is a non-executive director on the boards of Smith & Nephew Plc, Bunge Limited and CRISIL. Vinita Bali is a member of Nomination and Remuneration Committee, Corporate Social Responsibility Committee and Risk Management Committee.